HANSOH PHARMA(03692),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

03692 HANSOH PHARMA

Closed 07-02 16:08:21

31.520

+1.900

+6.41%

High31.860	Low29.780	Vol19.23M
Open30.240	D1 Closing29.620	Amplitude7.02%
Mkt Cap191.14B	Tradable Cap191.14B	Total Shares6.06B
T/O605.38M	T/O Rate0.32%	Tradable Shares6.06B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"03692","market":"HK","secType":"STK","nameCN":"HANSOH PHARMA","latestPrice":31.52,"timestamp":1782979701008,"preClose":29.62,"halted":0,"volume":19234243,"delay":0,"changeRate":0.06414584740040508,"floatShares":6064000000,"shares":6064000000,"eps":0.93,"marketStatus":"Closed","change":1.9,"latestTime":"07-02 16:08:21","open":30.24,"high":31.86,"low":29.78,"amount":605377971,"amplitude":0.070223,"askPrice":31.56,"askSize":26000,"bidPrice":31.5,"bidSize":30000,"shortable":3,"etf":0,"ttmEps":1.033788,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1783042200000},"marketStatusCode":5,"adr":0,"listingDate":1560441600000,"exchange":"SEHK","adjPreClose":29.62,"dividendRate":0.013916,"openAndCloseTimeList":[[1782955800000,1782964800000],[1782968400000,1782979200000]],"volumeRatio":1.422268,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03692","defaultTab":"news","newsList":[{"id":"1176467450","title":"Hansoh Pharma's HS-20136-2 Injection Receives NMPA Approval for Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1176467450","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176467450?lang=en_us&edition=fundamental","pubTime":"2026-07-02 20:14","pubTimestamp":1782994455,"startTime":"0","endTime":"0","summary":"The self-developed novel Class 1 drug HS-20136-2 injection from HANSOH PHARMA (03692) has received two drug clinical trial approval notices from China's National Medical Products Administration...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","03692","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648073535","title":"Hansoh Pharma Says China NMPA Clears Hs-20136-2 Injection for Clinical Trials in Type 2 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2648073535","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648073535?lang=en_us&edition=fundamental","pubTime":"2026-07-02 20:11","pubTimestamp":1782994299,"startTime":"0","endTime":"0","summary":"Hansoh Pharma says China NMPA clears HS-20136-2 injection for clinical trials in type 2 diabetesHansoh Pharmaceutical won China NMPA clinical trial clearances for HS-20136-2 injection, a self-develope","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nNDL5MqjTP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1191","BK1583","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648073355","title":"Hansoh Pharmaceutical - Clinical Trial Approvals for Hs-20136-2 Injection Issued- by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2648073355","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648073355?lang=en_us&edition=fundamental","pubTime":"2026-07-02 20:11","pubTimestamp":1782994276,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nFWN4340FD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03692","BK1583","BK1191","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648508357","title":"Hansoh Pharmaceutical Group Stock Rises 6.4% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2648508357","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648508357?lang=en_us&edition=fundamental","pubTime":"2026-07-02 16:30","pubTimestamp":1782981000,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Hansoh Pharmaceutical Group Co. Ltd. advanced 6.4% to 31.52 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.8% to 23055.03.Hansoh Pharmaceutical Group Co. Ltd. closed 29% short of its 52-week high of HK$44.22, which the company reached Jan. 15.Trading volume totaled 19.2 million shares, compared to the 50-day average of 10.4 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 02, 2026 04:30 ET Copyright  2026 Dow Jones & Company, Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","BK1191","BK1583","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189121903","title":"Movement Alert｜Hansoh Pharmaceutical Rises 6.01% in Regular Trading, Pemosatide Injection Approval Coupled with Pharma Sector Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1189121903","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189121903?lang=en_us&edition=fundamental","pubTime":"2026-07-02 10:58","pubTimestamp":1782961090,"startTime":"0","endTime":"0","summary":"On July 2, Hansoh Pharmaceutical rose 6.01% in regular trading, trading at 31.44 HKD/share, with turnover of approximately 205 million HKD.On the news front, the company announced on June 30 that its...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647535002","title":"Hansoh Pharmaceutical Group Stock Falls 2.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2647535002","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647535002?lang=en_us&edition=fundamental","pubTime":"2026-06-30 16:33","pubTimestamp":1782808380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Hansoh Pharmaceutical Group Co. Ltd. shed 2.3% to 29.62 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.6% to 22881.02.Hansoh Pharmaceutical Group Co. Ltd. closed 33% short of its 52-week high of HK$44.22, which the company achieved Jan. 15.Trading volume totaled 14.8 million shares, compared to the 50-day average of 10.3 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJune 30, 2026 04:33 ET Copyright  2026 Dow Jones & Company, Inc.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","BK1589","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107843829","title":"Movement Alert｜Hansoh Pharmaceutical Falls 3.03% in Regular Trading, Pharmaceutical Sector Under Broad Selling Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=1107843829","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107843829?lang=en_us&edition=fundamental","pubTime":"2026-06-30 11:01","pubTimestamp":1782788513,"startTime":"0","endTime":"0","summary":"On June 30, Hansoh Pharmaceutical fell 3.03% in regular trading, trading at HKD 29.4/share, with turnover of approximately HKD 93.81 million. The decline came amid broad-based weakness across the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647324154","title":"Hansoh Pharmaceutical Group Stock Rises 5.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2647324154","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647324154?lang=en_us&edition=fundamental","pubTime":"2026-06-29 16:30","pubTimestamp":1782721800,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Hansoh Pharmaceutical Group Co. Ltd. rallied 5.8% to 30.32 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.6% to 23026.68.The stock's rise snapped a three-day losing streak.Hansoh Pharmaceutical Group Co. Ltd. closed 31% below its 52-week high of HK$44.22, which the company reached Jan. 15.Trading volume totaled 14.0 million shares, compared to the 50-day average of 10.3 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJune 29, 2026 04:30 ET Copyright  2026 Dow Jones & Company, Inc.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","BK1589","BK1191","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176060253","title":"Movement Alert｜Hansoh Pharmaceutical Rises 4.88% in Regular Trading, Pharma Sector Rally Combines with Dense Pipeline Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=1176060253","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176060253?lang=en_us&edition=fundamental","pubTime":"2026-06-29 10:48","pubTimestamp":1782701290,"startTime":"0","endTime":"0","summary":"On June 29, Hansoh Pharmaceutical rose 4.88% in regular trading, trading at HK$30.06/share, with turnover of HK$125 million. The move was driven by broad pharmaceutical sector strength and a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646574953","title":"Hansoh Pharma Shareholders Approved 2026 Share Scheme at AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2646574953","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646574953?lang=en_us&edition=fundamental","pubTime":"2026-06-26 20:44","pubTimestamp":1782477868,"startTime":"0","endTime":"0","summary":"Hansoh Pharma shareholders approved 2026 share scheme at AGMHansoh Pharmaceutical Group held its annual general meeting on June 26, 2026 to vote on shareholder resolutions.Shareholders adopted the aud","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL19CJtp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Hansoh Pharma Shareholders Approved 2026 Share Scheme at AGM","news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","03692","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645589371","title":"Hansoh Pharmaceutical Group Stock Slides 1.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2645589371","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645589371?lang=en_us&edition=fundamental","pubTime":"2026-06-24 16:33","pubTimestamp":1782289980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Hansoh Pharmaceutical Group Co. Ltd. slipped 1.3% to 29.22 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.3% to 23412.18.Hansoh Pharmaceutical Group Co. Ltd. closed 34% below its 52-week high of HK$44.22, which the company reached Jan. 15.Trading volume totaled 12.7 million shares, compared to the 50-day average of 10.1 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJune 24, 2026 04:33 ET Copyright  2026 Dow Jones & Company, Inc.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","BK1589","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175832743","title":"Movement Alert｜Hansoh Pharmaceutical Rises 3.18% in Regular Trading, Receives Inaugural Buy Rating from Guosheng Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=1175832743","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175832743?lang=en_us&edition=fundamental","pubTime":"2026-06-24 10:36","pubTimestamp":1782268579,"startTime":"0","endTime":"0","summary":"On June 24, Hansoh Pharmaceutical rose 3.18% in regular trading, trading at 30.38 HKD/share, with turnover of approximately 180 million HKD.On the news front, Guosheng Securities recently initiated...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645097657","title":"Hansoh Pharmaceutical Group (SEHK:3692) Stock Could Be Below Fair Value After Hang Seng Index Inclusion","url":"https://stock-news.laohu8.com/highlight/detail?id=2645097657","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645097657?lang=en_us&edition=fundamental","pubTime":"2026-06-21 15:21","pubTimestamp":1782026475,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group (SEHK:3692) has been added to the Hang Seng China Enterprises Index, an index inclusion that can affect how capital flows into the stock as passive funds adjust their holdings.\nSee our latest analysis for Hansoh Pharmaceutical Group.\nAt a latest share price of HK$29.96, Hansoh Pharmaceutical Group has seen its 1 month share price return decline 12.14%, while its 1 year total shareholder return is 8.20% and its 3 year total shareholder return is very large. This...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3692/hansoh-pharmaceutical-group-shares/news/hansoh-pharmaceutical-group-sehk3692-stock-could-be-below-fa","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3692/hansoh-pharmaceutical-group-shares/news/hansoh-pharmaceutical-group-sehk3692-stock-could-be-below-fa","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1191","DCF","03692","BK1583","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643756939","title":"Hansoh Pharma releases in vitro study data on HS-20094 dual-biased GLP-1/GIP agonist at ENDO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2643756939","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643756939?lang=en_us&edition=fundamental","pubTime":"2026-06-16 18:35","pubTimestamp":1781606127,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical reported in vitro pharmacology findings for HS-20094, a dual-biased GLP-1/GIP receptor agonist, at ENDO 2026.Results have already been presented, positioning the candidate as designed to preserve efficacy while reducing gastrointestinal side effects.Data indicated a receptor-activity balance favoring GIP signaling, a profile often associated with improved tolerability versus GLP-1–dominant approaches.Study readouts suggested reduced receptor desensitization mechanisms, supporting a strategy for more sustained signaling with potentially fewer adverse events.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hansoh Pharmaceutical Group Co. Ltd. published the original content used to generate this news brief on June 16,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL6m98h7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","03692","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642265619","title":"Hansoh Pharmaceutical Group  Stock Rallies 2.6% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2642265619","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642265619?lang=en_us&edition=fundamental","pubTime":"2026-06-12 16:32","pubTimestamp":1781253120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Hansoh Pharmaceutical Group Co. Ltd. rallied 2.6% to 29.98 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.9% to 24718.10.Hansoh Pharmaceutical Group Co. Ltd. closed 32% short of its 52-week high of HK$44.22, which the company reached Jan. 15.Trading volume totaled 15.4 million shares, compared to the 50-day average of 10.8 million shares.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","03692","BK1191","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642136252","title":"Hansoh Pharma posts 80% MMR at week 48 in phase 1b HS-10382 plus flumatinib trial for newly diagnosed CML-CP","url":"https://stock-news.laohu8.com/highlight/detail?id=2642136252","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642136252?lang=en_us&edition=fundamental","pubTime":"2026-06-12 14:10","pubTimestamp":1781244652,"startTime":"0","endTime":"0","summary":"Hansoh Pharma presented EHA 2026 data on HS-10382, a new BCR::ABL1 allosteric inhibitor for newly diagnosed chronic-phase CML.Two early studies showed encouraging disease-control signals with generally manageable safety, supporting further development of HS-10382.One trial tested HS-10382 with flumatinib as first-line therapy; results pointed to faster, deeper responses versus typical expectations.A separate investigator-led study of HS-10382 alone showed similar early efficacy with favorable tolerability at the tested dose.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hansoh Pharmaceutical Group Co. Ltd. published the original content used to generate this news brief on June 12, 2026, and is solely responsible for the information co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nNDL9svyCh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","03692","BK1191","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642752064","title":"Hansoh Pharmaceutical Group (SEHK:3692) Valuation Check After Hang Seng China Enterprises Index Inclusion","url":"https://stock-news.laohu8.com/highlight/detail?id=2642752064","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642752064?lang=en_us&edition=fundamental","pubTime":"2026-06-11 01:18","pubTimestamp":1781111934,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group added to Hang Seng China Enterprises Index\nHansoh Pharmaceutical Group (SEHK:3692) has been added to the Hang Seng China Enterprises Index, a move that increases the stock’s visibility and may influence flows from index-linked funds.\nSee our latest analysis for Hansoh Pharmaceutical Group.\nAlongside the index inclusion, Hansoh Pharmaceutical Group’s share price has been under pressure recently. It has a 30 day share price return of down 20.12% and a year to date...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3692/hansoh-pharmaceutical-group-shares/news/hansoh-pharmaceutical-group-sehk3692-valuation-check-after-h","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3692/hansoh-pharmaceutical-group-shares/news/hansoh-pharmaceutical-group-sehk3692-valuation-check-after-h","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["03692","BK1583","BK1191","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191405798","title":"Hansoh Pharma Appoints Guo Ying as Joint Company Secretary Following Zhong Shengli’s Resignation","url":"https://stock-news.laohu8.com/highlight/detail?id=1191405798","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191405798?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:45","pubTimestamp":1781088303,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group Company Limited (Hansoh Pharma) has announced a leadership change within its corporate governance team. Effective 10 June 2026, Zhong Shengli has resigned as joint company...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185744156","title":"Hansoh Pharma’s NDA for HS-10568 Injection Accepted by China’s NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1185744156","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185744156?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:44","pubTimestamp":1781088297,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group Company Limited (Hansoh Pharma) disclosed that the National Medical Products Administration (NMPA) formally accepted the New Drug Application (NDA) for HS-10568 Injection...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141642657","title":"HANSOH PHARMA Receives NMPA Acceptance for New Drug Application of HS-10568 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1141642657","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141642657?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:44","pubTimestamp":1781088290,"startTime":"0","endTime":"0","summary":"HANSOH PHARMA (03692) has announced that the New Drug Application for its innovative product, HS-10568 injection, has been accepted for review by China's National Medical Products Administration.The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","BK1589","BK1583","BK1191","03692"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0007},{"period":"1month","weight":-0.0579},{"period":"3month","weight":-0.2084},{"period":"6month","weight":-0.179},{"period":"1year","weight":0.0068},{"period":"ytd","weight":-0.179}],"compareEarnings":[{"period":"1week","weight":-0.0195},{"period":"1month","weight":-0.0914},{"period":"3month","weight":-0.0954},{"period":"6month","weight":-0.1073},{"period":"1year","weight":-0.0495},{"period":"ytd","weight":-0.1073}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Hansoh Pharmaceutical Group Company Ltd is an investment holding company primarily engaged in the research and development, production and sale of a series of pharmaceutical products. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The Company mainly conducts its business in the domestic market.","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":-0.002565},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.01282},{"month":3,"riseRate":0.428571,"avgChangeRate":0.023369},{"month":4,"riseRate":0.571429,"avgChangeRate":0.03396},{"month":5,"riseRate":0.571429,"avgChangeRate":-0.00521},{"month":6,"riseRate":0.571429,"avgChangeRate":0.039406},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.000332},{"month":8,"riseRate":0.714286,"avgChangeRate":0.01897},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.033021},{"month":10,"riseRate":0.142857,"avgChangeRate":0.001586},{"month":11,"riseRate":0.714286,"avgChangeRate":0.063467},{"month":12,"riseRate":0.571429,"avgChangeRate":0.016858}],"exchange":"SEHK","name":"HANSOH PHARMA","nameEN":"HANSOH PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"HANSOH PHARMA(03692),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest HANSOH PHARMA(03692) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"HANSOH PHARMA,03692,HANSOH PHARMA股票,HANSOH PHARMA股票老虎,HANSOH PHARMA股票老虎国际,HANSOH PHARMA行情,HANSOH PHARMA股票行情,HANSOH PHARMA股价,HANSOH PHARMA股市,HANSOH PHARMA股票价格,HANSOH PHARMA股票交易,HANSOH PHARMA股票购买,HANSOH PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"HANSOH PHARMA(03692),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest HANSOH PHARMA(03692) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}